^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ET1402L1-ARTEMIS T cells

    i
    Other names: ET1402L1-ARTEMIS T cells, ET140202
    Associations

    News

    Trials
    Company:
    Eureka Therap
    Drug class:
    γδ TCR modulator, Alpha fetoprotein inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma (clinicaltrials.gov)
    P1, N=12, Completed, First Affiliated Hospital Xi'an Jiaotong University | Recruiting --> Completed | N=27 --> 12 | Trial completion date: Jan 2020 --> Dec 2020
    Clinical • Trial completion • Enrollment change • Trial completion date
    |
    HLA-A (Major Histocompatibility Complex, Class I, A) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
    |
    ET1402L1-ARTEMIS T cells